These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 4683071)

  • 1. Pharmacology of orally administered 9 -tetrahydrocannabinol.
    Perez-Reyes M; Lipton MA; Timmons MC; Wall ME; Brine DR; Davis KH
    Clin Pharmacol Ther; 1973; 14(1):48-55. PubMed ID: 4683071
    [No Abstract]   [Full Text] [Related]  

  • 2. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man.
    Lemberger L; Crabtree RE; Rowe HM
    Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
    Gill EW; Jones G; Lawrence DK
    Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man.
    Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H
    Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular effects of delta-9-tetrahydrocannabinol in man.
    Weiss JL; Watanabe AM; Lemberger L; Tamarkin NR; Cardon PV
    Clin Pharmacol Ther; 1972; 13(5):671-84. PubMed ID: 4559810
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood levels of 3 H- 9 -tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons.
    McMillan DE; Dewey WL; Turk RF; Harris LS; McNeil JH
    Biochem Pharmacol; 1973 Feb; 22(3):383-97. PubMed ID: 4687134
    [No Abstract]   [Full Text] [Related]  

  • 7. Biliary excretion of delta1-tetrahydrocannabinol and its metabolites in the rat.
    Widman M; Nordqvist M; Agurell S; Lindgren JE; Sandberg F
    Biochem Pharmacol; 1974 Apr; 23(7):1163-72. PubMed ID: 4823449
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood and brain levels of delta1-tetrahydrocannabinol in mice--the effect of 7-hydroxy-delta1-tetrahydrocannabinol.
    Gill EW; Lawrence DK
    Biochem Pharmacol; 1974 Mar; 23(6):1140-3. PubMed ID: 4824912
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of fasting on the absorption and effects of delta9-tetrahydrocannabinol after oral administration in sesame oil.
    Pryor GT; Husain S; Mitoma C
    Pharmacol Biochem Behav; 1977 Mar; 6(3):331-41. PubMed ID: 558623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the effects of 1 -tetrahydrocannabinol ( 1 -THC) and DDT on the hepatic microsomal metabolism of 1 -THC and other compounds in the rat.
    Kupfer D; Levin E; Burstein SH
    Chem Biol Interact; 1973 Jan; 6(1):59-66. PubMed ID: 4689910
    [No Abstract]   [Full Text] [Related]  

  • 11. Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol.
    Levy S; McCallum NK
    Experientia; 1975 Nov; 31(11):1268-9. PubMed ID: 1204768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.
    Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME
    Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of delta 9-tetrahydrocannabinol in saliva of men by means of thin-layer chromatography and mass spectrometry.
    Just WW; Filipovic N; Werner G
    J Chromatogr; 1974 Sep; 96(2):189-94. PubMed ID: 4412740
    [No Abstract]   [Full Text] [Related]  

  • 14. Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
    Gill EW; Jones G
    Biochem Pharmacol; 1972 Aug; 21(16):2237-48. PubMed ID: 4674983
    [No Abstract]   [Full Text] [Related]  

  • 15. Tetrahydrocannabinol, sesame oil and biogenic amines: a preliminary report.
    Anton AH; Serrano A; Beyer RD; Lavappa KS
    Life Sci; 1974 May; 14(9):1741-6. PubMed ID: 4407739
    [No Abstract]   [Full Text] [Related]  

  • 16. Increase of serum prolactin in male rats by (minus)-trans-delta9-tetrahydrocannabinol.
    Daley JD; Branda LA; Rosenfeld J; Younglai EV
    J Endocrinol; 1974 Nov; 63(2):415-6. PubMed ID: 4443705
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats.
    Kaymakçalan S; Sivil S
    Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891
    [No Abstract]   [Full Text] [Related]  

  • 18. Cannabis and alcohol: effects on stimulated car driving.
    Rafaelsen OJ; Bech P; Christiansen J; Christrup H; Nyboe J; Rafaelsen L
    Science; 1973 Mar; 179(4076):920-3. PubMed ID: 4569248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.
    Lemberger L; Martz R; Rodda B; Forney R; Rowe H
    J Clin Invest; 1973 Oct; 52(10):2411-7. PubMed ID: 4729039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory effects of delta-9-tetrahydrocannabinol.
    Bellville JW; Swanson GD; Aqleh KA
    Clin Pharmacol Ther; 1975 May; 17(5):541-8. PubMed ID: 1126111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.